দেশ: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: HMA (Heads of Medicines Agencies)
oxantel embonate 200.28 mg, praziquantel 125 mg, pyrantel embonate 124.85 mg
Vetoquinol
QP52AA51
Tablet
praziquantel, combinations
Dogs
2011-09-30
SEPTEMBER 2011 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT France EXETEC 25 United-Kingdom The Blue Cross – Dog Wormer for large dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substances Oxantel 500.70 mg (equivalent to 1397.5 mg of oxantel embonate) Pyrantel 124.85 mg (equivalent to 360 mg of pyrantel embonate) Praziquantel 125.00 mg Excipient to one 2375 mg divisible tablet Excipients For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow, oblong tablet with breaking line. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: _ _ _ _ _Toxocara canis_ _ _ _ _ _Toxascaris leonina _ _ _ _ _ _Ancylostoma caninum_ _ _ _ _ _Uncinaria stenocephala _ _ _ _ _ _Trichuris vulpis_ Cestodes: _ _ _ _ _Dipylidium caninum _ _ _ _ _ _Taenia _spp _ _ _ _ _Echinococcus multilocularis_ _ _ _ _ _Echinococcus granulosus_ 4.3 CONTRAINDICATIONS See section 4.8 SEPTEMBER 2011 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class Fleas serve as intermediate hosts for one of the common tapeworms – _Dipylidium caninum_. Tapeworm infestation may reoccur unless control of সম্পূর্ণ নথি পড়ুন